Objective: The aim of this study was to assess the effect of local injections of betamethasone, hyaluronidase and lidocaine in patients with Peyronie's disease.

Material And Methods: A total of 112 men who had a palpable plaque at the penis and suffered from painful erection and bending of penis was treated with a total of 12 injections containing betamethasone, hyaluronidase and lidocaine. Patients were classified into groups according to the duration of the disease (<6 months, 6-12 months or >12 months) as well as the size of the plaque (<10 mm, 10-20 mm or >20 mm). Pretreatment evaluation of patients and assessment of outcome were based on subjective criteria as well as measurement of the size of the plaque by means of ultrasound. Results were correlated to patients' characteristics.

Results: The overall response rate was 86%. Cure or improvement was noticed in 31% and 55% of patients respectively. Most of the patients (83%) had a duration of disease less than 12 months. Painful erection, bending of penis and plaque were absent in 97%, 32% and 31% of patients, respectively, after treatment. No severe complications were observed. The effect of treatment was strongly related to the duration of disease and the size of the plaque.

Conclusions: The method is safe, well tolerated by patients and characterized by a high response rate in patients with a history of less than 12 months and a plaque not exceeding 20 mm.

Download full-text PDF

Source
http://dx.doi.org/10.1080/003655900455422DOI Listing

Publication Analysis

Top Keywords

betamethasone hyaluronidase
12
duration disease
12
injections betamethasone
8
hyaluronidase lidocaine
8
patients
8
lidocaine patients
8
painful erection
8
erection bending
8
bending penis
8
disease months
8

Similar Publications

Article Synopsis
  • Phimosis is a condition where the foreskin cannot be retracted, and this study aims to compare the effectiveness of two topical treatments—betamethasone alone versus betamethasone combined with hyaluronidase—in children aged 3-10 years.
  • A total of 152 children participated, with treatments applied for 60 days, and results showed a success rate of 75.38% for the combination treatment compared to 64.06% for betamethasone alone, though this difference was not statistically significant.
  • The study found no systemic absorption of cortisol from either treatment and concluded that both topical therapies are safe and effective, with no significant influence from factors like age or previous corticosteroid use
View Article and Find Full Text PDF

Background: Eventually Oral submucous fibrosis causes pronounced stiffness and failure to open the mouth. Objectives are to determine compare the efficacy of intralesional steroids alone and combination of steroids with hyaluronidase on mouth opening in oral submucous fibrosis.

Methods: It was a prospective comparative cohort study.

View Article and Find Full Text PDF

Delayed adverse reaction to a natural dermal filler mimicking salivary gland neoplasia.

Bull Natl Res Cent

April 2022

Department of Oral Pathology, Faculty of Health Sciences, University of the Witwatersrand, WITS, Private Bag 3, Johannesburg, 2050 South Africa.

Background: Cosmetic dermal fillers are a sought-after procedure globally. However, despite the safety claims of filler materials by the manufacturers, adverse reactions still occur.

Case Presentation: This case report is of a 66-year-old female who presented with a late-onset complication of a hyaluronic acid dermal filler that clinically mimicked a salivary gland neoplasm.

View Article and Find Full Text PDF

Topical corticosteroids for phimosis in children: a network meta-analysis of randomized clinical trials.

Pediatr Surg Int

August 2021

Department of Dental Training, Ministry of Health, Manama, Kingdom of Bahrain.

Background: Corticosteroids and hyaluronidase are trialed for treating phimosis in children. We carried out the present network meta-analysis to compare the therapeutic effect of these drugs.

Methods: Electronic databases were searched for appropriate randomized clinical trials.

View Article and Find Full Text PDF

Objectives: To assess the efficacy of betamethasone, hyaluronidase and its combination on mouth opening, burning sensation and quality of life (QOL) in patients with oral submucous fibrosis.

Study Design: Sixty patients were divided in 4 groups; group A received 8 mg of betamethasone, group B received 3000 IU of hyaluronidase, group C received the combination of betamethasone and hyaluronidase and group D received saline injections biweekly for 5 weeks. Patients were also assessed using QOL questionnaire.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!